Czech National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GA
VF
Czech National Bank's REGN Position: Q2 2026 in Review
Czech National Bank increased its Regeneron Pharmaceuticals (REGN) stake by 3.6% in Q2 2026, buying an estimated $673K and bringing the position to 28,442 shares worth $17.7M. The position accounts for 0.1% of the portfolio, ranked #190.
Czech National Bank first reported a position in REGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.7M in Q3 2024. 406 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Czech National Bank held 28,442 shares of Regeneron Pharmaceuticals worth $17.7M as of Q2 2026.
- Czech National Bank bought 989 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $673K.
- Regeneron Pharmaceuticals made up 0.1% of Czech National Bank's portfolio in Q2 2026, its #190 holding.
- Czech National Bank first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- Czech National Bank's Regeneron Pharmaceuticals position peaked at $22.7M in Q3 2024.
- 406 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.